Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cass

Showing results (241-250 of 289) with videos related to

Pageof 29
Sort By:
Journal of the American Society of Nephrology : JASN|May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney diseaseRichard Haynes, David Lewis, Jonathan Emberson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2016
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled TrialMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2019
Varying Association of Extended Hours Dialysis with Quality of LifeBrendan Smyth, Oliver van den Broek-Best, Daqing Hong, et al.
The Lancet. Infectious Diseases|October 15, 2013
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trialDavid W Johnson, Sunil V Badve, Elaine M Pascoe, et al.
European Journal of Preventive Cardiology|March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular diseaseVanessa Selak, Chris Bullen, Sandrine Stepien, et al.
Journal of Hypertension|May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialToshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 14, 2014
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trialDavid W Johnson, Elaine M Pascoe, Sunil V Badve, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Pageof 29

Showing results (241-250 of 289) with videos related to

Sort By:
Pageof 29
Journal of the American Society of Nephrology : JASN|May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney diseaseRichard Haynes, David Lewis, Jonathan Emberson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2016
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled TrialMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 2, 2019
Varying Association of Extended Hours Dialysis with Quality of LifeBrendan Smyth, Oliver van den Broek-Best, Daqing Hong, et al.
The Lancet. Infectious Diseases|October 15, 2013
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trialDavid W Johnson, Sunil V Badve, Elaine M Pascoe, et al.
European Journal of Preventive Cardiology|March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular diseaseVanessa Selak, Chris Bullen, Sandrine Stepien, et al.
Journal of Hypertension|May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialToshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 14, 2014
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trialDavid W Johnson, Elaine M Pascoe, Sunil V Badve, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetesToshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Pageof 29